Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Wire Cambodia.
Press releases published on August 5, 2025
Neuronetics Reports Second Quarter 2025 Financial and Operating Results
GlobeNewswire
·
August 5, 2025
Delivered $38.1 million total revenue in the quarter, representing 18% adjusted pro forma revenue growth Generated record Greenbrook clinic revenue of $23.0 million in the quarter Reduced cash used in operations to $3.5 million, beating guidance of under $ …
Cartesian Therapeutics Announces New Employment Inducement Grants
GlobeNewswire
·
August 5, 2025
FREDERICK, Md., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of inducement awards to two …
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for July 2025 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics
GlobeNewswire
·
August 5, 2025
Stockholm, 5 August 2025 - Virtune today announces the completion of the monthly rebalancing for the Virtune Crypto Top 10 Index ETP, listed on Nasdaq Stockholm for both the SEK-denominated (ISIN code SE0020052207, ticker name VIR10SEK) and the EUR- …
Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för juli 2025 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP
GlobeNewswire
·
August 5, 2025
Stockholm, 5 augusti 2025 - Virtune meddelar idag att man har slutfört den månatliga rebalanseringen för Virtune Crypto Top 10 Index ETP SEK / EUR som är noterad på Nasdaq Stockholm för både SEK-varianten (ISIN-kod SE0020052207, tickernamn VIR10SEK) och …
Adaptec® SmartRAID 4300 Series of Accelerators Deliver Scalable, Secure NVMe® RAID Storage Solutions
GlobeNewswire
·
August 5, 2025
CHANDLER, Ariz., Aug. 05, 2025 (GLOBE NEWSWIRE) -- To better support server OEMs, storage systems, data centers and enterprise customers, Microchip Technology (Nasdaq: MCHP) has launched the Adaptec® SmartRAID 4300 series of NVMe® RAID storage accelerators …
SynOx Therapeutics Completes Enrollment in Registrational Phase 3 TANGENT Clinical Trial Significantly Ahead of Timeline
GlobeNewswire
·
August 5, 2025
DUBLIN and OXFORD, United Kingdom and PHILADELPHIA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced …
TEN Protocol Launches Community-First Raise: Infrastructure Ownership for the Next Era of Ethereum
GlobeNewswire
·
August 5, 2025
Early users gain direct access to proven Ethereum Layer 2 infrastructure, on the same terms as institutions. LONDON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- TEN Protocol, the Ethereum Layer 2 building encrypted execution for next-gen blockchain applications, is …
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
August 5, 2025
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update Three active immunotherapies for precision prevention of neurodegeneration progressing through Phase 2 clinical development ACI-7104.056 anti-alpha-synuclein active …
MoonLake Immunotherapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
August 5, 2025
Phase 3 VELA program in hidradenitis suppurativa (HS) on track for an expected primary endpoint readout around September 2025 and an expected submission of a Biologic License Application (BLA) in the United States in mid-2026 Other clinical trials of …
Envision Pharma Group appoints Tom Langan as Chief Executive Officer
GlobeNewswire
·
August 5, 2025
Envision Pharma Group appoints Tom Langan as Chief Executive Officer Leading industry executive with 30 years’ of experience providing technology-enabled solutions to life sciences companies Fairfield, Connecticut, USA, and Horsham, United Kingdom - August …
Elicio Therapeutics Announces Positive Recommendation by IDMC to Continue ELI-002 7P Randomized Phase 2 Study in Pancreatic Cancer Without Modifications to Final Analysis
GlobeNewswire
·
August 5, 2025
The AMPLIFY-7P study of ELI-002 7P successfully passes event-driven interim analysis for efficacy, futility, and safety by the IDMC The Company views the IDMC’s positive recommendation as an indication that ELI-002 7P has shown preliminary signals of …
Xtract One Chosen by Volusia County Schools to Advance School Safety
GlobeNewswire
·
August 5, 2025
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its Xtract One Gateway (“Gateway”) system has been chosen by Volusia County Schools in Volusia County, …
Foghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update
GlobeNewswire
·
August 5, 2025
FHD-909 (LY4050784) Phase 1 dose escalation trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population, is enrolling well and remains on track Preclinical synergistic benefit of FHD-909 in combination …
Sagimet Biosciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
August 5, 2025
SAN MATEO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management …
Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 5, 2025
Second-quarter 2025 Rezdiffra™ (resmetirom) net sales of $212.8 million As of June 30, 2025, more than 23,000 patients on Rezdiffra Received new U.S. Rezdiffra patent providing protection to Feb. 4, 2045 Announced global licensing agreement for an oral GLP …
Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
August 5, 2025
– First patient dosed in combination trial of TNG462 and Revolution Medicines RAS(ON) inhibitors – – First patient dosed in Phase 1/2 trial with TNG456, a brain-penetrant MTA-cooperative PRMT5 inhibitor in development for glioblastoma – BOSTON, Aug. 05, …
Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings
GlobeNewswire
·
August 5, 2025
$56.2 million in proceeds from completed public offering and concurrent private equity purchase by Medtronic and Ligand $55 million in proceeds and funding commitments from royalty-based, non-dilutive investments from Medtronic and Ligand Proceeds extend …
Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
August 5, 2025
BBI-355 and BBI-825 combination arm of the POTENTIATE trial is now open for enrollment BBI-940 is on track for submission of an investigational new drug application in the first half of 2026 $127 million in cash supports operations into the first half of …
CareCloud Reports Second Quarter 2025 Results
GlobeNewswire
·
August 5, 2025
Delivers first quarter of positive GAAP EPS in Company’s history since going public, announces initial results from AI Initiative SOMERSET, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a …
Symbotic Unveils Next-Generation Storage for its Warehouse Automation System – Enabling Significantly Reduced Customer Footprint and Faster Case Handling
GlobeNewswire
·
August 5, 2025
Innovative Design Provides Ultra-High Density for Increased Storage Capacity and/or Reduced Footprint Denser Storage Enables Shorter and Faster Bot Trips per Case Delivery Pre-Assembled Components Deliver Faster Implementation in Customer Sites, …